Compatibility of Insect Growth Regulators with Eretmocerus eremicus (Hymenoptera: Aphelinidae) for Whitefly (Homoptera: Alyerodidae) Control on Poinsettias: II. Trials in Commercial Poinsettia Crops

The efficacy and cost of reduced release rates of the parasitoid Eretmocerus eremicus Rose and Zolnerowich (Hymenoptera: Aphelinidae) when combined with application of the insect growth regulator buprofezin were compared to those of a higher parasitoid release rate used alone for whitefly control (Homoptera: Aleyrodidae) on poinsettia (Euphorbia pulcherrima Willd. ex Koltz.). The trial was conducted in seven greenhouses in Methuen, Massachusetts from August through December 1997 and employed commercial poinsettia production practices. Two whiteflies species, Trialeurodes vaporariorum (Westwood) and Bemisia argentifolii Bellows and Perring (= Bemisia tabaci [Gennadius] strain B), were present. Three treatments were examined: (1) E. eremicus used alone at a release rate of three females per plant per week (two greenhouses); (2) E. eremicus at an intermediate release rate of two females per plant per week, combined with mid-season use of buprofezin (two applications, spaced 1 week apart, applied in weeks 9 and 10) (two greenhouses); and (3) E. eremicus at a low release rate of one female per plant per week, combined with mid-season use of buprofezin, applied as in treatment 2 (two greenhouses). In addition, observations were made in one additional greenhouse at the site, in which the grower used pesticides for whitefly control. Prior to the start of the trial, cuttings used for all treatments experienced some pesticide use, first abamectinduring rooting and later buprofezin at potting to reduce whitefly numbers, which were initially very high. At harvest, densities of live whitefly nymphs were not statistically different among the biological control treatments, indicating that a low parasitoid release rate combined with buprofezin was as effective as a higher release rate of the parasitoid used alone. Nymphal densities in separate market samples (based on smaller sample sizes) showed differences among treatments, but all treatments, including the low parasitoid release rate + buprofezin maintained densities of live nymphs + pupae at or below approximately two per leaf, a level commercially acceptable in local markets. Control costs per single-stemmed poinsettia plant were $1.18 for the high parasitoid release treatment, $0.75 for the treatment of weekly releases of two female parasitoids per plant per week + buprofezin, $0.38 for the treatment of releases of one female parasitoid per plant per week + buprofezin, and $0.14 for the chemical control greenhouse.